Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.54 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CDK1 | P06493 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.46 |
| ▸ | GSK3A | P49840 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5670334 | 0.87 | P2RX7 (0.52) | HPGDALDH1A1P2RX7KDM4CHTT | |
| SCHEMBL27847330 | 0.85 | P2RX7 (0.51) | HPGDALDH1A1P2RX7KDM4CHTT | |
| SCHEMBL2017132 | 0.84 | ALDH1A1 (0.73) | HPGDALDH1A1HTTGAAKMT2A | |
| SCHEMBL3921086 | 0.84 | P2RX7 (0.57) | HPGDALDH1A1P2RX7KDM4CHTT | |
| SCHEMBL7034976 | 0.82 | HPGD (0.43) | HPGDALDH1A1P2RX7KDM4CHTT | |
| SCHEMBL5929981 | 0.81 | HPGD (0.50) | HPGDALDH1A1P2RX7HTTGAA | |
| SCHEMBL17646067 | 0.81 | RIPK1 (0.46) | HPGDALDH1A1P2RX7HTTGAA | |
| SCHEMBL3131049 | 0.81 | P2RX7 (0.56) | HPGDALDH1A1P2RX7GAAKMT2A | |
| SCHEMBL3126847 | 0.81 | P2RX7 (0.56) | HPGDP2RX7LMNA | |
| SCHEMBL8765952 | 0.81 | GAA (0.51) | HPGDALDH1A1P2RX7KDM4CHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023667-A1 | Composition For Preventing Harmful Organisms | MITSUI CHEMICALS, INC. (JP) | 2009-01-22 | — | — | US | claimed |
| EP-2003968-A2 | COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PRODUCTS, SO INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF | Leschot Sanhueza, Andres Antonio (CL) | 2008-12-24 | — | — | EP | claimed |
| EP-1872658-A1 | PESTICIDAL COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2008-01-02 | — | — | EP | claimed |
| US-20070232495-A1 | Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof | NAPPA ALVARO O | 2007-10-04 | — | — | US | claimed |
| WO-2007110801-A2 | COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PORDUCTS, INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF | LESCHOT SANHUEZA ANDRES ANTONI (CL) | 2007-10-04 | — | — | WO | claimed |
| US-20050171064-A1 | Insecticide for Acarina comprising synergistic mixture including a 4-nitroimino or 4-cyanoimino 1,3,5-oxadiazine such as 5-(2-chlorothiazol-5-ylmethyl)-3-methyl-4-nitroimino-perhydro-1,3,5-oxadiazine and another pesticide such as pirimicarb | SENN ROBERT (CH) | 2005-08-04 | — | — | US | claimed |
| CN-110325040-B | Plant disease control composition and method for controlling plant disease using same | 三井化学AGRO株式会社 | 2022-04-05 | — | — | CN | disclosed |
| EP-3710453-A1 | SINGLE ENANTIOMER ANTIPARASITIC COMPOUNDS | Avista Pharma Solutions, Inc. (US) | 2020-09-23 | — | — | EP | disclosed |
| CN-110325040-A | Plant disease control composition and apply its plant disease the method for control | 三井化学AGRO株式会社 | 2019-10-11 | — | — | CN | disclosed |
| WO-2018009751-A1 | ANTIPARASITIC COMPOUNDS | AVISTA PHARMA SOLUTIONS, INC. (US) | 2018-01-11 | — | — | WO | disclosed |
| WO-2017201134-A1 | SYNTHETIC PROCESS AND NOVEL INTERMEDIATES | AVISTA PHARMA SOLUTIONS, INC. (US) | 2017-11-23 | — | — | WO | disclosed |
| EP-3245209-A1 | ANTIPARASITIC COMPOUNDS | Avista Pharma Solutions, Inc. (US) | 2017-11-22 | — | — | EP | disclosed |
| WO-2016183173-A1 | ANTIPARASITIC COMPOUNDS | Avista Pharma Solutions (US) | 2016-11-17 | — | — | WO | disclosed |
| CN-101160052-A | Pesticidal composition | MITSUI CHEMICALS INC (JP) | 2008-04-09 | — | — | CN | disclosed |
| EP-1872658-A1 | PESTICIDAL COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-20070232495-A1 | Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof | NAPPA ALVARO O | 2007-10-04 | — | — | US | disclosed |
| WO-2007110801-A2 | COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PORDUCTS, INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF | LESCHOT SANHUEZA ANDRES ANTONI (CL) | 2007-10-04 | — | — | WO | disclosed |
| EP-1165527-A1 | PESTICIDAL ENANTIOMER-PURE 2,4-DISUBSTITUTED OXAZOLINES | Novartis AG (CH) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000058291-A1 | PESTICIDAL ENANTIOMER-PURE 2,4-DISUBSTITUTED OXAZOLINES | NOVARTIS AG (CH) | 2000-10-05 | — | — | WO | disclosed |
| EP-0255760-A1 | A process for the production of a granule-shaped composition comprising agricultural chemical compound | MEIJI SEIKA KAISHA LTD. (JP) | 1988-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171064-A1 | Insecticide for Acarina comprising synergistic mixture including a 4-nitroimino or 4-cyanoimino 1,3,5-oxadiazine such as 5-(2-chlorothiazol-5-ylmethyl)-3-methyl-4-nitroimino-perhydro-1,3,5-oxadiazine and another pesticide such as pirimicarb | CNPY2, CBR3, CNPY3 | HPGD 1823/4885ALDH1A1 2115/4885P2RX7 174/4885 |
| US-20070232495-A1 | Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof | C5, PNN, NQO1 | HPGD 955/4885ALDH1A1 3137/4885P2RX7 2948/4885 |
| US-20090023667-A1 | Composition For Preventing Harmful Organisms | DDT, CBR3, AHR | HPGD 3824/4885ALDH1A1 439/4885P2RX7 2395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.